The Medical Letter on Drugs and Therapeutics
Issue 1530
Drugs for Cognitive Loss and Dementia; Tocilizumab (Actemra) for Giant Cell Arteritis; Comparison Table: Drugs for Alzheimer's Disease (online only)
The full issue is available to subscribers Subscriber Login   
Drugs for Cognitive Loss and Dementia
Alzheimer's disease (AD) is the most common cause of dementia, but cognitive loss is also associated with other neurological conditions such as Parkinson's disease, dementia with Lewy bodies, vascular dementia, and frontotemporal dementia. ... more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this issue:
Title: Issue 1530
Select version:
 Downloadable, electronic issue - $35
 Postal, hardcopy issue - $35